Outcomes of Hepatosplenic T Cell Lymphoma – The Mayo Clinic Experience

Hepatosplenic T-cell Lymphoma (HSTCL) is an aggressive subtype of peripheral T cell lymphoma. Prospective trials providing therapeutic guidance are lacking due to rarity of the disease. We studied the clinical characteristics and therapeutic outcomes of 22 patients with HSTCL. Liver involvement and chronic immunosuppression prior to diagnosis were associated with worse prognosis.

Source: Clinical Lymphoma, Myeloma and Leukemia - October 4, 2020 Category: Hematology Authors: Leyla Bojanini, Liuyan Jiang, Alexander J. Tun, Ernesto Ayala, David M. Menke, Bradford Hoppe, Mohamed A. Kharfan-Dabaja, Han W. Tun, Muhamad Alhaj Moustafa Tags: Original Study Source Type: research